Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Healthcare Industry News Bone Biologics prices $5m equity and warrant offering to accelerate spinal fusion trial development Bone Biologics Corporation has priced a $5 million public offering to advance its spine fusion therapy trials and intellectual property. Learn what this means for investors. byPallavi MadhirajuJune 29, 2025